CHANNEL BY TOPICS

QUICK LINKS

PSI Presents on Clinical Trial Feasibility

ZUG, Switzerland --(Business Wire)--

PSI
CRO, a full-service contract research organization, announced today
that Kasia Moscicka, Director Feasibility Research and Patient
Recruitment Services, presented on the changing dynamic of clinical
trial feasibility at recent PCMG meeting held in Lisbon, Portugal.

To coincide with the 10th anniversary of the PCMG conference, Ms.
Moscicka, PSI's Director of Feasibility, gave a fascinating presentation
discussing how the feasibility process has evolved over the last 10
years, why conducting thorough feasibility is more important today than
it ever was and what we can all learn to ensure we handle the increasing
complexity inherent in conducting clinical
trial feasibility in a sophisticated and appropriate manner.

During her talk, Ms. Moscicka also presented feedback from a recent
survey sent out to industry members to learn more about how different
companies approach feasibility studies, what levl of control they allow
CROs in terms of country/site selection & protocol adaptation,
what return on investment do they feel feasibilities provide and what
level of accountability for success they expect a CRO to take once they
have performed a feasibility and how willing CROs are to do this.

The presentation evoked considerable interest from industry
representatives. As inquiries and meeting requests keep arriving
following the PCMG talk, be aware that PSI representatives will be
available for consultation and further discussion at the upcoming Outsourcing
in Clinical Trials UK & Ireland conference to be held on June 25th
- 26th at the Royal Garden Hotel, Kensington.

About PSI CRO AG:PSI
is a Swiss-based privately-owned, full-service
contract research organization (CRO), operating globally. PSI's
reputation on the market place is that of a no-nonsense CRO, capable of
saving pharmaceutical sponsors millions of development dollars by
consistently meeting clinical trial timelines. PSI's global
reach supports the operations of clinical trials across multiple
countries and continents. PSI is known to be highly selective about the
work that they pursue. PSI has exceptionally high repeat and referral
business rates, while maintaining minimal staff turnover indicative of
its commitment to be the best CRO in the world as measured by its
customers and its employees. Global headquarters are located in Zug
(Zürich), Switzerland at 113a Baarerstrasse 6300. www.psi-cro.com